Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 105401-105450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04215029
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans
NAActive, not recruiting
6 participants
Started: Aug 27, 2019 · Completed: Jul 31, 2026
12 conditions3 sponsors1 location
NCT03713203
PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV).
NARecruiting
24 participants
Started: Aug 27, 2019 · Completed: Aug 27, 2026
2 conditions3 sponsors1 location
NCT04189822
Hearts in Rhythm Organization (HiRO)National Registry and Bio Bank
N/AEnrolling by invitation
10,000 participants
Started: Aug 27, 2019 · Completed: Dec 31, 2026
6 conditions2 sponsors1 location
NCT04666077
Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
NARecruiting
100 participants
Started: Aug 27, 2019 · Completed: Jul 31, 2025
2 conditions1 sponsor2 locations
NCT04039633
Spinal Cord Stimulation for Refractory Pain in Erythromelalgia
NARecruiting
24 participants
Started: Aug 26, 2019 · Completed: Jan 31, 2026
1 condition2 sponsors4 locations
NCT04067037
Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma
PHASE2Recruiting
60 participants
Started: Aug 26, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03900793
Losartan + Sunitinib in Treatment of Osteosarcoma
PHASE1Recruiting
41 participants
Started: Aug 26, 2019 · Completed: Feb 28, 2027
1 condition4 sponsors4 locations
NCT04080492
A Cardiac Disease Quality of Life Study
N/ARecruiting
1,200 participants
Started: Aug 26, 2019 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT03849443
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
EARLY_PHASE1Recruiting
604 participants
Started: Aug 26, 2019 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT04053322
Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.
PHASE2Active, not recruiting
172 participants
Started: Aug 26, 2019 · Completed: Aug 31, 2027
2 conditions3 sponsors2 locations
NCT03724175
The Role of Secondary Bile Acids in Intestinal Inflammation
PHASE2/PHASE3Recruiting
15 participants
Started: Aug 26, 2019 · Completed: Dec 31, 2050
2 conditions1 sponsor1 location
NCT03967743
Application of a Systematic Developmental Assessment to a Novel Population: Infants With Rare Genetic Disorders
N/ARecruiting
150 participants
Started: Aug 26, 2019 · Completed: Dec 1, 2025
5 conditions1 sponsor1 location
NCT04157322
Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis
N/AActive, not recruiting
55 participants
Started: Aug 26, 2019 · Completed: Oct 31, 2025
4 conditions1 sponsor1 location
NCT04010201
A Registered Cohort Study on Brain Calcification
N/ARecruiting
2,000 participants
Started: Aug 25, 2019 · Completed: Dec 31, 2079
1 condition3 sponsors1 location
NCT03840226
The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients
PHASE3Recruiting
320 participants
Started: Aug 25, 2019 · Completed: Mar 1, 2026
2 conditions2 sponsors1 location
NCT04072588
Sacrospinous Ligament Fixation and Lateral Suspension Operations
N/AActive, not recruiting
80 participants
Started: Aug 24, 2019 · Completed: Aug 24, 2026
2 conditions1 sponsor1 location
NCT03702257
DSA Intragraft in Lung Transplantation: Diagnostic and Prognostic Value in Antibody Mediated Rejection
NARecruiting
80 participants
Started: Aug 23, 2019 · Completed: Feb 22, 2026
3 conditions1 sponsor5 locations
NCT04126018
Comparative Imaging Assessment of Valvular Heart Disease
N/ARecruiting
200 participants
Started: Aug 23, 2019 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT04057924
Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN
N/ARecruiting
200 participants
Started: Aug 23, 2019 · Completed: Sep 1, 2029
2 conditions1 sponsor1 location
NCT04087473
Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC
N/ARecruiting
50 participants
Started: Aug 23, 2019 · Completed: Dec 31, 2025
2 conditions2 sponsors5 locations
NCT03875547
Post-marketing Surveillance (Use Result Surveillance) With Refixia®
N/AEnrolling by invitation
20 participants
Started: Aug 23, 2019 · Completed: Sep 30, 2025
1 condition1 sponsor17 locations
NCT03382938
Dexmedetomidine Wound Infiltration in Cesarean Section
NARecruiting
100 participants
Started: Aug 23, 2019 · Completed: Nov 20, 2026
1 condition1 sponsor1 location
NCT04009265
Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma
PHASE3Recruiting
819 participants
Started: Aug 23, 2019 · Completed: Jul 1, 2027
1 condition1 sponsor1 location
NCT04772768
Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease
N/ARecruiting
500 participants
Started: Aug 23, 2019 · Completed: Jul 23, 2029
3 conditions1 sponsor1 location
NCT04430075
MiCLASP Post Market Clinical Follow-Up (PMCF) Study
N/ARecruiting
1,000 participants
Started: Aug 23, 2019 · Completed: Mar 31, 2031
2 conditions1 sponsor37 locations
NCT04043494
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
PHASE3Recruiting
683 participants
Started: Aug 23, 2019 · Completed: Nov 22, 2027
1 condition2 sponsors228 locations
NCT05782465
Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)
N/AActive, not recruiting
500 participants
Started: Aug 23, 2019 · Completed: Dec 31, 2033
1 condition8 sponsors8 locations
NCT03979131
Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC)
PHASE2Active, not recruiting
40 participants
Started: Aug 22, 2019 · Completed: Jun 15, 2026
2 conditions1 sponsor1 location
NCT04737382
Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed.
NARecruiting
200 participants
Started: Aug 22, 2019 · Completed: Aug 22, 2024
1 condition2 sponsors6 locations
NCT03875638
Treating Hyperexcitability in AD With Levetiracetam
PHASE2Recruiting
85 participants
Started: Aug 22, 2019 · Completed: Nov 30, 2025
4 conditions1 sponsor1 location
NCT03924401
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant
PHASE2Active, not recruiting
30 participants
Started: Aug 22, 2019 · Completed: Jan 31, 2026
1 condition5 sponsors9 locations
NCT03789240
Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
PHASE2Active, not recruiting
33 participants
Started: Aug 22, 2019 · Completed: Jan 1, 2027
3 conditions1 sponsor1 location
NCT04132440
Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease
N/AActive, not recruiting
17 participants
Started: Aug 22, 2019 · Completed: May 1, 2030
2 conditions2 sponsors1 location
NCT03733093
PREVAIL VIII: A CoHOrt Clinical, Viral, and ImmuNOlogic Monitoring Study of People Living With Retroviral Infection in Liberia (HONOR)
N/AActive, not recruiting
1,377 participants
Started: Aug 22, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor4 locations
NCT05087888
MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation
N/AActive, not recruiting
9 participants
Started: Aug 22, 2019 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT04098133
Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital
N/ARecruiting
100 participants
Started: Aug 22, 2019 · Completed: Jun 30, 2029
1 condition1 sponsor1 location
NCT05608590
What is the Best Moment for Performing an HSG in Women With a Unfulfilled Childwish
PHASE4Recruiting
554 participants
Started: Aug 22, 2019 · Completed: Jan 1, 2026
1 condition2 sponsors1 location
NCT03914612
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
PHASE3Active, not recruiting
813 participants
Started: Aug 22, 2019 · Completed: Sep 26, 2026
16 conditions3 sponsors397 locations
NCT03904147
TRILUMINATE Pivotal Trial
NAActive, not recruiting
572 participants
Started: Aug 21, 2019 · Completed: Apr 30, 2029
1 condition1 sponsor76 locations
NCT03912519
Parallel Versus Perpendicular Technique for Lumbar Medial Branch Radiofrequency Neurotomy
NAEnrolling by invitation
132 participants
Started: Aug 21, 2019 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT04132310
Mother Infant Nutrition Study
N/AEnrolling by invitation
180 participants
Started: Aug 21, 2019 · Completed: Dec 31, 2025
2 conditions1 sponsor2 locations
NCT03719079
Nanowear Heart Failure Management Multi-sensor Algorithm
N/ARecruiting
500 participants
Started: Aug 21, 2019 · Completed: Dec 31, 2024
1 condition3 sponsors1 location
NCT03879629
Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure
PHASE2Active, not recruiting
184 participants
Started: Aug 21, 2019 · Completed: Feb 28, 2027
1 condition3 sponsors5 locations
NCT04033237
Project 4, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Pregnant Women
PHASE1/PHASE2Active, not recruiting
66 participants
Started: Aug 21, 2019 · Completed: Jul 31, 2024
1 condition4 sponsors2 locations
NCT04023422
Clinic Navigation and Home Visits to Improve Guideline-based Care and Outcomes in Low Income Minority Adults With Asthma
NAActive, not recruiting
367 participants
Started: Aug 21, 2019 · Completed: Apr 30, 2026
1 condition2 sponsors2 locations
NCT04095195
Registry of Subjects at Risk of Pancreatic Cancer
N/ARecruiting
1,000 participants
Started: Aug 20, 2019 · Completed: Sep 20, 2045
7 conditions1 sponsor4 locations
NCT03437928
DBS for Depression
NARecruiting
12 participants
Started: Aug 20, 2019 · Completed: Aug 19, 2026
1 condition2 sponsors2 locations
NCT04044859
ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)
PHASE1Active, not recruiting
120 participants
Started: Aug 20, 2019 · Completed: Apr 30, 2037
9 conditions2 sponsors17 locations
NCT03643861
RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)
NARecruiting
40 participants
Started: Aug 20, 2019 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT04069884
RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer
NARecruiting
540 participants
Started: Aug 20, 2019 · Completed: Dec 31, 2030
2 conditions2 sponsors1 location